The bill mandates that pharmacy practice sites in New Jersey must display a notice about insulin manufacturer assistance programs on their websites and provide pamphlets about these programs upon request from individuals purchasing insulin prescriptions. The notice and pamphlet will be created by the Department of Health, which is also responsible for adopting rules and regulations to implement the act. Additionally, insulin manufacturers can notify the department if they wish to be included in the notices and pamphlets.

The act is set to take effect on the first day of the twelfth month following its enactment, although the Commissioner of Health is permitted to take necessary administrative actions in advance to ensure its implementation.